To investigate whether the protective effect of the anti-IL-16 nAb against sepsis-induced cardiac injury was mediated by the Nrf2 pathway, CPUY192018 was used to inhibit the Nrf2 pathway in mice with LPS-induced sepsis. The gene discussed is NFE2L2; the disease is Sepsis.